Calamos Advisors’s Spectral AI MDAI Stock Holding History

Calamos Advisors’s Portfolio MDAI Stock Details MDAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-244,578	Closed	-$2.41M	–	1288
2022 Q3	$2.41M	Buy	+244,578	New	+$2.41M	0.01%	841

Other funds holding MDAI

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ETH

Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Calamos Advisors's MDAI Position: Q4 2022 in Review

Calamos Advisors sold out of Spectral AI (MDAI) in Q4 2022, closing a stake of 244,578 shares — an estimated $2.41M sold.

Calamos Advisors first reported a position in MDAI in Q3 2022 and held it in 1 quarter. The position peaked at $2.41M in Q3 2022. 11 funds tracked by Wall St. Rank hold MDAI as of Q4 2022.

Calamos Advisors reported no remaining Spectral AI position as of Q4 2022 after selling out during the quarter.
Calamos Advisors sold 244,578 Spectral AI shares in Q4 2022, an estimated $2.41M.
Calamos Advisors first reported a position in Spectral AI in Q3 2022 and held it in 1 quarter.
Calamos Advisors's Spectral AI position peaked at $2.41M in Q3 2022.
11 funds tracked by Wall St. Rank held Spectral AI as of Q4 2022.

Based on Calamos Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.